Market Size – USD 15.09 billion in 2020 Market Growth – 11.8% Market Trends – increasing demand for lab-on-a-chip technology
The global Microfluidics Market size is expected to reach USD
35.23 billion by 2028 at a CAGR of 11.8% according to a new report by Reports
and Data.
Microfluidics has been used in the study of antibiotic-resistant bacteria, nanoparticle transport in blood, and chemical reaction kinetics, to name a few. As a result of the increased importance of research, the microfluidics market is expected to rise in revenue. Cancer and pathogen detection are two diagnostic applications of microfluidics that have tremendous economic and technical potential for the microfluidics industry. Microfluidic instruments are used to measure molecular diffusion coefficients, fluid viscosity, pH, and chemical binding coefficients. In the pharmaceutical industry, microfluidic systems are used for a variety of analytical purposes in biopharmaceutical production, including monitoring and optimising protein drug production and assays involving human cells.
The costly R&D process needed to develop microfluidic
devices and make them commercially viable may be a stumbling block for the microfluidics
industry. However, attempts are being made to make this possible.
Asia Pacific is projected to be the fastest-growing area
due to advanced research infrastructure, low labour costs, and the adoption of
microfluidic platforms. This underserved market has piqued the attention of
foreign investors.
Ask for Sample Report @ https://www.reportsanddata.com/sample-enquiry-form/3871
Key Highlights from the Report
·
In February 2021, Fluidigm, a market leader in microfluidics,
announced that fourth-quarter revenues rose 38 percent year over year as demand
for COVID-19 research drove sales. According to estimates, the company's
microfluidics revenues grew by 98 percent in Q4 to USD 21 million.
·
In order to resolve fluid volume manipulation issues in current
microfluidic control systems, Fluigent developed the MFCSTM series of
microfluidic systems based on its patented FASTAB technology, which features
pressure-controlled flow control that allows a pulseless flow and greater
responsiveness.
·
In recent years, microfluidics has become increasingly important
in PCR because it allows for the integration of the entire biological process,
resulting in multiplexed, high-throughput, and highly parallel assays. As a
result, the medical technology segment led the industry in terms of sales.
·
Due to the coronavirus pandemic, demand for microfluidic PCR
devices has skyrocketed. Every day, millions of tests were demanded to identify
the virus and to distinguish the infected from the healthy. In 2020, the
microfluidics industry witnessed unprecedented sales growth as a result of
this.
·
In 2020, the lab-on-a-chip segment dominated the microfluidics
industry, and this dominance is expected to continue during the forecast
period.
·
In 2020, the PDMS-based microfluidic chips segment had the
largest revenue share, and it is projected to rise at the fastest rate during
the forecast period.
·
Due to the presence of well-established industry leaders,
financial support and resource availability for microfluidics research,
advanced technologies, and high demand for POC diagnostics, the microfluidics
market in North America held the largest revenue share.
·
Some of the key industry contributors are Illumina, Inc.; F.
Hoffmann-La Roche Ltd; PerkinElmer, Inc.; Agilent Technologies, Inc.; Bio-Rad
Laboratories, Inc.; Danaher Corporation; Life Technologies Corporation; Abbott
Laboratories Thermo Fisher Scientific; Qiagen; Biomérieux; Elveflow; Cellix
Ltd.; Micronit Micro Technologies B.V.; and Fluidigm Corporation.
Request
a customization of the report @ https://www.reportsanddata.com/request-customization-form/3871
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels
and provides an analysis of the latest industry trends in each of the
sub-segments from 2018 to 2028. For this study, Reports and Data has segmented
the global microfluidics market report based on technology, application,
material, and region:
Technology Outlook (Revenue, USD Million, 2018 - 2028)
·
Medical/Healthcare
o
PCR & RT-PCR
o
Gel Electrophoresis
o
Microarrays
o
ELISA
o
Others
·
Non-Medical
Application Outlook (Revenue, USD Million, 2018 - 2028)
·
Lab-on-a-chip
o
Medical
o
Non-Medical
·
Organs-on-chips
o
Medical
o
Non-Medical
·
Continuous flow microfluidics
o
Medical
o
Non-Medical
·
Optofluidics and microfluidics
o
Medical
o
Non-Medical
·
Acoustofluidics and microfluidics
o
Medical
o
Non-Medical
·
Electrophoresis and microfluidics
o
Medical
o
Non-Medical
Material Outlook (Revenue, USD Million, 2018 - 2028)
·
Silicon
·
Glass
·
Polymer
·
PDMS
·
Others
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3871
Regional Outlook (Revenue, USD Million, 2018 - 2028)
·
North America
o
The U.S.
o
Canada
·
Europe
o
The U.K.
o
Germany
o
France
·
Asia Pacific
o
India
o
China
o
Japan
·
Latin America
o
Brazil
o
Mexico
·
Middle East & Africa
o
South Africa
Key
queries addressed in the report:
1. What
is the impact of the COVID-19 pandemic on the Microfluidics global landscape?
2.
What is the estimated market size for
the forecast period?
3.
What are the recent developments
observed in the Microfluidics sector?
4.
How is the sector expected to progress
in the post-COVID period?
5.
Who are the leading players in the
global business landscape?
6.
Which regions are dominating the
overall market?
7.
What are the key trends predicted to
impact the future development of the industry?
8.
What are the growth opportunities
existing in the sector?
9.
Which factors are expected to curtail
industry growth in the coming years?
10. What
are the prevalent strategic initiatives undertaken by dominant players?
For Further Details On this Report @ https://www.reportsanddata.com/request-customization-form/3871
The Microfluidics Market report is updated with the latest economic scenario with the value, drivers, constraints, demand and supply ratio, production capacity, import/export status, growth rate, and others. Additionally, the report also undertakes SWOT examination and Porter’s Five Forces Analysis to assess the leading companies.
Browse More Reports:
Oncology Information System Market Share
About Us:
Reports
and Data is a market research and consulting company that provides syndicated
research reports, customized research reports, and consulting services. Our
solutions purely focus on your purpose to locate, target and analyze consumer
behavior shifts across demographics, across industries and help client’s make a
smarter business decision. We offer market intelligence studies ensuring
relevant and fact-based research across a multiple industries including
Healthcare, Technology, Chemicals, Power and Energy. We consistently update our
research offerings to ensure our clients are aware about the latest trends
existent in the market.
Contact Us:
John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports
and Data | Web: www.reportsanddata.com
News: www.reportsanddata.com/market-news
Connect
with us: Facebook | LinkedIn | Twitter
No comments:
Post a Comment